M. Pascual, Strategies to Improve Long-Term Outcomes after Renal Transplantation, New England Journal of Medicine, vol.346, issue.8, pp.580-90, 2002.
DOI : 10.1056/NEJMra011295

N. Siddiqi, M. A. Mcbride, and S. Hariharan, Similar risk profiles for posttransplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis, Kidney Int, issue.5, pp.65-1906, 2004.
DOI : 10.1111/j.1523-1755.2004.00589.x

URL : http://doi.org/10.1111/j.1523-1755.2004.00589.x

K. Solez, Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (?CAN?), American Journal of Transplantation, vol.5, issue.52, pp.518-544, 2007.
DOI : 10.1111/j.1600-6143.2004.00526.x

R. B. Colvin, Emerging role of B cells in chronic allograft dysfunction, Kidney International, vol.78, issue.119, pp.2010-2023
DOI : 10.1038/ki.2010.436

R. B. Colvin, Antibody-Mediated Renal Allograft Rejection: Diagnosis and Pathogenesis, Journal of the American Society of Nephrology, vol.18, issue.4, pp.1046-56, 2007.
DOI : 10.1681/ASN.2007010073

M. Crespo, Acute humoral rejection in renal allograft recipients: I

S. Mauiyyedi, Acute humoral rejection in kidney transplantation: II

M. J. Everly, Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss, American Journal of Transplantation, vol.86, issue.5, pp.1063-71, 2009.
DOI : 10.1111/j.1600-6143.2009.02577.x

N. Lachmann, Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts, Transplantation, vol.87, issue.10, pp.1505-1518, 2009.
DOI : 10.1097/TP.0b013e3181a44206

P. C. Lee, HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss, Transplantation, vol.88, issue.4, pp.568-74, 2009.
DOI : 10.1097/TP.0b013e3181b11b72

J. E. Worthington, Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome, Transplantation, issue.7, pp.75-1034, 2003.

Q. Mao, Extremely High Association Between Appearance of HLA Antibodies and Failure of Kidney Grafts in a Five-Year Longitudinal Study, American Journal of Transplantation, vol.17, issue.4, pp.864-71, 2007.
DOI : 10.1097/01.tp.0000180564.14050.49

P. I. Terasaki and M. Ozawa, Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial, American Journal of Transplantation, vol.72, issue.3, pp.438-481, 2004.
DOI : 10.1111/j.1600-6143.2004.00360.x

K. Mizutani, Serial Ten-Year Follow-Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure, American Journal of Transplantation, vol.283, issue.1, pp.2265-72, 2005.
DOI : 10.1111/j.1600-6143.2004.00360.x

P. I. Terasaki, M. Ozawa, and R. Castro, Four-year Follow-up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft Survival, American Journal of Transplantation, vol.17, issue.2, pp.408-423, 2007.
DOI : 10.1016/S1074-7613(00)80448-3

M. S. Leffell and A. A. Zachary, Anti-allograft antibodies: some are harmful, some can be overcome, and some may be beneficial, Discov Med, issue.948, pp.478-84, 2010.

G. Bartel, Posttransplant HLA Alloreactivity in Stable Kidney Transplant Recipients-Incidences and Impact on Long-Term Allograft Outcomes, American Journal of Transplantation, vol.76, issue.12, pp.2652-60, 2008.
DOI : 10.1111/j.1600-6143.2008.02428.x

M. S. Leffell and A. A. Zachary, Antiallograft antibodies: relevance, detection, and monitoring, Current Opinion in Organ Transplantation, vol.15, issue.1, pp.2-7, 2010.
DOI : 10.1097/MOT.0b013e3283342798

H. Heinrichs and H. T. Orr, HLA non-A,B,C class I genes: Their structure and expression, Immunologic Research, vol.86, issue.4, pp.265-74, 1990.
DOI : 10.1007/BF02935526

P. Paul, Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells, Human Immunology, vol.61, issue.11, pp.61-1138, 2000.
DOI : 10.1016/S0198-8859(00)00197-X

URL : https://hal.archives-ouvertes.fr/hal-00092861

B. Favier, Research on HLA-G: an update, Tissue Antigens, vol.24, issue.3, pp.207-218, 2007.
DOI : 10.1097/00002030-200202150-00005

M. Colonna, A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells, The Journal of Experimental Medicine, vol.138, issue.11, pp.186-1809, 1997.
DOI : 10.1038/321700a0

M. Colonna, Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules, J Immunol, vol.160, issue.7, pp.3096-100, 1998.

J. P. Goodridge, KIR2DL4 (CD158d) Genotype Influences Expression and Function in NK Cells, The Journal of Immunology, vol.171, issue.4, pp.1768-74, 2003.
DOI : 10.4049/jimmunol.171.4.1768

A. Kikuchi-maki, KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production

E. D. Carosella, The tolerogenic molecule HLA-G, Immunology Letters, vol.138, issue.1, pp.22-26, 2011.
DOI : 10.1016/j.imlet.2011.02.011

B. Riteau, HLA-G inhibits the allogeneic proliferative response, Journal of Reproductive Immunology, vol.43, issue.2, pp.203-214, 1999.
DOI : 10.1016/S0165-0378(99)00034-0

B. Riteau, HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis, The Journal of Immunology, vol.166, issue.8, pp.166-5018, 2001.
DOI : 10.4049/jimmunol.166.8.5018

V. Ristich, Tolerization of dendritic cells by HLA-G, European Journal of Immunology, vol.84, issue.4, pp.1133-1175, 2005.
DOI : 10.1002/eji.200425741

S. Fournel, Cutting Edge: Soluble HLA-G1 Triggers CD95/CD95 Ligand-Mediated Apoptosis in Activated CD8+ Cells by Interacting with CD8, The Journal of Immunology, vol.164, issue.12, pp.164-6100, 2000.
DOI : 10.4049/jimmunol.164.12.6100

J. Lemaoult, HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells, Proceedings of the National Academy of Sciences, vol.101, issue.18, pp.7064-7073, 2004.
DOI : 10.1073/pnas.0401922101

L. Rond and S. , Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions:in vivo implications in transplanted patients, European Journal of Immunology, vol.34, issue.3, pp.649-60, 2004.
DOI : 10.1002/eji.200324266

A. Naji, Soluble HLA-G and HLA-G1 Expressing Antigen-Presenting Cells Inhibit T-Cell Alloproliferation through ILT-2/ILT-4/FasL-Mediated Pathways, Human Immunology, vol.68, issue.4, pp.233-242, 2007.
DOI : 10.1016/j.humimm.2006.10.017

R. Bahri, Soluble HLA-G Inhibits Cell Cycle Progression in Human Alloreactive T Lymphocytes, The Journal of Immunology, vol.176, issue.3, pp.1331-1340, 2006.
DOI : 10.4049/jimmunol.176.3.1331

N. Rouas-freiss, Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis, Proceedings of the National Academy of Sciences, vol.94, issue.21, pp.94-11520, 1997.
DOI : 10.1073/pnas.94.21.11520

E. Fainardi, Emerging topics and new perspectives on HLA-G, Cellular and Molecular Life Sciences, vol.168, issue.Suppl, pp.433-51, 2011.
DOI : 10.1007/s00018-010-0584-3

S. Liang, B. Baibakov, and A. Horuzsko, HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor, European Journal of Immunology, vol.32, issue.9, pp.2418-2444, 2002.
DOI : 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L

R. Sheshgiri, Myocardial HLA-G Reliably Indicates a Low Risk of Acute Cellular Rejection in Heart Transplant Recipients, The Journal of Heart and Lung Transplantation, vol.27, issue.5, pp.522-529, 2008.
DOI : 10.1016/j.healun.2008.02.004

O. Brugiere, Immunohistochemical Study of HLA-G Expression in Lung Transplant Recipients, American Journal of Transplantation, vol.79, issue.Suppl 1, pp.1427-1465, 2009.
DOI : 10.1111/j.1600-6143.2009.02650.x

B. Basturk, Human Leukocyte Antigen-G, a New Parameter in the Follow-up of Liver Transplantation, Transplantation Proceedings, vol.38, issue.2, pp.571-575, 2006.
DOI : 10.1016/j.transproceed.2005.12.108

C. Creput, Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation, Journal of Hepatology, vol.39, issue.4, pp.587-94, 2003.
DOI : 10.1016/S0168-8278(03)00354-4

C. Creput, Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver???kidney transplantation: possible implications for monitoring patients, Human Immunology, vol.64, issue.11, pp.64-1033, 2003.
DOI : 10.1016/j.humimm.2003.08.356

V. Rebmann, Soluble total human leukocyte antigen class I and human leukocyte antigen???G molecules in kidney and kidney/pancreas transplantation, Human Immunology, vol.70, issue.12
DOI : 10.1016/j.humimm.2009.07.016

J. Qiu, Soluble HLA-G Expression and Renal Graft Acceptance, American Journal of Transplantation, vol.17, issue.9, pp.2152-2158, 2006.
DOI : 10.1084/jem.183.2.699

J. C. Crispim, Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection, Transplant Immunology, vol.18, issue.4, pp.361-368, 2008.
DOI : 10.1016/j.trim.2007.10.010

K. Solez, Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions, American Journal of Transplantation, vol.23, issue.4, pp.753-60, 2008.
DOI : 10.1046/j.1523-1755.1999.00299.x

B. Sis and P. F. Halloran, Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection, Current Opinion in Organ Transplantation, vol.15, issue.1, pp.42-50, 2010.
DOI : 10.1097/MOT.0b013e3283352a50

V. Zarkhin, Expression of Soluble HLA-G Identifies Favorable Outcomes in Liver Transplant Recipients, Transplantation, vol.90, issue.9, pp.1000-1005, 2010.
DOI : 10.1097/TP.0b013e3181f546af

R. Sheshgiri, Association Between HLA-G Expression and C4d Staining in Cardiac Transplantation, Transplantation, vol.89, issue.4, pp.480-481, 2010.
DOI : 10.1097/TP.0b013e3181ca88d5

P. Moreau, Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts, Transplantation Proceedings, vol.33, issue.3, pp.2277-80, 2001.
DOI : 10.1016/S0041-1345(01)01990-X

URL : https://hal.archives-ouvertes.fr/hal-00092865

J. Luque, Soluble HLA-G in Heart Transplantation: Their Relationship to Rejection Episodes and Immunosuppressive Therapy, Human Immunology, vol.67, issue.4-5, pp.4-5, 2006.
DOI : 10.1016/j.humimm.2006.02.034

R. Bahri, Dendritic Cells Secrete the Immunosuppressive HLA-G Molecule upon CTLA4-Ig Treatment: Implication in Human Renal Transplant Acceptance, The Journal of Immunology, vol.183, issue.11, pp.183-7054, 2009.
DOI : 10.4049/jimmunol.0803054

M. Ozawa, Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience, Clin Transpl, pp.265-90, 2006.

R. J. Duquesnoy, Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes, Transplant Immunology, vol.18, issue.4, pp.352-60, 2008.
DOI : 10.1016/j.trim.2007.10.001

T. Kobayashi, Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation, Human Immunology, vol.72, issue.1, pp.11-18, 2011.
DOI : 10.1016/j.humimm.2010.10.018

E. F. Campos, Post-Transplant Anti-HLA Class II Antibodies as Risk Factor for Late Kidney Allograft Failure, American Journal of Transplantation, vol.71, issue.10, pp.2316-2336, 2006.
DOI : 10.1038/nri1702

L. L. Langan, Post-Transplant HLA class II Antibodies and High Soluble CD30 Levels are Independently Associated with Poor Kidney Graft Survival, American Journal of Transplantation, vol.13, issue.4, pp.847-56, 2007.
DOI : 10.1016/j.humimm.2003.08.201

N. Issa, Transplant Glomerulopathy: Risk and Prognosis Related to Anti-Human Leukocyte Antigen Class II Antibody Levels, Transplantation, vol.86, issue.5, pp.681-686, 2008.
DOI : 10.1097/TP.0b013e3181837626

I. Kaczmarek, Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant, Exp Clin Transplant, vol.6, issue.3, pp.229-264, 2008.